FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Dermatomyositis (DM) · Juvenile Dermatomyositis (JDM)
Bethesda, United States
Clinical Trials Live
Explore public ClinicalTrials.gov records by country, condition, phase and recruitment status. Find a study, review its eligibility criteria, and connect with the listed research team.
Registry counts refresh hourly when this page is visited.
Public records · ClinicalTrials.gov · recently updated first
Dermatomyositis (DM) · Juvenile Dermatomyositis (JDM)
Bethesda, United States
Vulvo Vaginal Atrophy (VVA)
Saint Paul, United States
Brain Tumor · Cancer
Bethesda, United States
Tuberculosis
Gaborone, Botswana; Molepolole, Botswana; Port-au-Prince, Haiti +7 more
Moderate-to-severe Plaque Psoriasis
Beijing, China
Anatomic Stage IV Breast Cancer AJCC v8 · Chemotherapy-Induced Peripheral Neuropathy · Metastatic Breast Carcinoma
Irvine, United States; Orange, United States; Clearwater, United States +26 more
Myelodysplastic Syndromes
Bethesda, United States
Metastatic Castration-Resistant Prostate Carcinoma · Prostate Adenocarcinoma · Stage IV Prostate Cancer AJCC v8
Seattle, United States
Advanced Solid Tumour
Hefei, China; Fuzhou, China; Guangzhou, China +12 more
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · HER2-Positive Breast Carcinoma · Invasive Breast Carcinoma
Birmingham, United States; Phoenix, United States; Los Angeles, United States +83 more
Non-Small Cell Lung Cancer, NSCLC · KRAS, NRAS, HRAS-mutated NSCLC · KRAS G12C-mutated Solid Tumors, Lung Cancer · Lung Cancer Stage IV, Advanced Solid Tumor, Cancer · RAS G12D-mutated NSCLC
Gilbert, United States; Duarte, United States; Irvine, United States +78 more
Intracranial Meningioma · Recurrent Meningioma · NF2 Gene Mutation
Birmingham, United States; Anchorage, United States; Fairbanks, United States +481 more
This catalogue includes records registered on ClinicalTrials.gov, including studies outside India. It does not include every study in every national registry. PharmaBharat does not run studies, assess eligibility or enrol participants.